SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-058101
Filing Date
2017-09-20
Accepted
2017-09-20 16:58:36
Documents
5
Period of Report
2017-09-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-22232_38k.htm 8-K 42406
2 EX-1.1 a17-22232_3ex1d1.htm EX-1.1 195281
3 EX-5.1 a17-22232_3ex5d1.htm EX-5.1 22135
4 GRAPHIC g222323kqi001.gif GRAPHIC 2160
5 GRAPHIC g222323kqi002.gif GRAPHIC 1714
  Complete submission text file 0001104659-17-058101.txt   266591
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37719 | Film No.: 171094428
SIC: 2834 Pharmaceutical Preparations